• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.76% Nasdaq Up 1.04%

    Theravance Inc. (THRX)

    -NasdaqGS
    13.45 Down 0.11(0.82%) 3:26PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:13.56
    Open:13.71
    Bid:13.39 x 100
    Ask:13.43 x 100
    1y Target Est:14.20
    Beta:3.00304
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:13.37 - 13.97
    52wk Range:10.58 - 23.84
    Volume:305,639
    Avg Vol (3m):565,043
    Market Cap:1.58B
    P/E (ttm):N/A
    EPS (ttm):-0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXDown 0.82%1.58B
    PFEUp 1.39%202.78B
    AZNUp 0.71%79.25B

    Key Statistics

    Forward P/E (1 yr):33.50
    P/S (ttm):61.49
    Ex-Dividend Date:08-Sep-15

    Analysts

    Annual EPS Est (Dec-15) :-0.14
    Quarterly EPS Est (Sep-15) :-0.03
    Mean Recommendation*:3.2
    PEG Ratio (5 yr expected):0.56

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback